Holdings of PROFUND VP PHARMACEUTICALS
ProFunds · Original filing · Compare with another fund · Report an error
- Net assets
- 10.2M $ including 9.8M $ in equities, 96.0 %
- Positions
- 59 in 4 countries
- Top ten
- 20.1 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Enliven Therapeutics Inc | 6,101 | 239.2K $ | 2.35 % |
| 2 | Corcept Therapeutics Inc | 5,551 | 223.8K $ | 2.20 % |
| 3 | Terns Pharmaceuticals Inc | 4,004 | 211.1K $ | 2.08 % |
| 4 | Perrigo Co PLC | 19,092 | 205K $ | 2.02 % |
| 5 | Axsome Therapeutics Inc | 1,174 | 198.4K $ | 1.95 % |
| 6 | Innoviva Inc | 8,354 | 194.6K $ | 1.91 % |
| 7 | Merck & Co Inc | 1,612 | 193.9K $ | 1.91 % |
| 8 | Pfizer Inc | 6,860 | 192.6K $ | 1.89 % |
| 9 | Royalty Pharma PLC | 4,011 | 192.4K $ | 1.89 % |
| 10 | Elanco Animal Health Inc | 7,987 | 191.1K $ | 1.88 % |
| 11 | Jazz Pharmaceuticals PLC | 1,010 | 190.9K $ | 1.88 % |
| 12 | Esperion Therapeutics Inc | 69,630 | 190.8K $ | 1.88 % |
| 13 | Edgewise Therapeutics Inc | 6,043 | 190.4K $ | 1.87 % |
| 14 | MBX Biosciences Inc | 6,369 | 190.1K $ | 1.87 % |
| 15 | Definium Therapeutics Inc | 10,053 | 190K $ | 1.87 % |
| 16 | Bristol-Myers Squibb Co | 3,123 | 189.4K $ | 1.86 % |
| 17 | ANI Pharmaceuticals Inc | 2,455 | 188.8K $ | 1.86 % |
| 18 | Johnson & Johnson | 771 | 188.5K $ | 1.85 % |
| 19 | Tarsus Pharmaceuticals Inc | 2,680 | 188K $ | 1.85 % |
| 20 | Trevi Therapeutics Inc | 15,686 | 187.1K $ | 1.84 % |
| 21 | Pacira BioSciences Inc | 8,204 | 185.4K $ | 1.82 % |
| 22 | Zoetis Inc | 1,563 | 184.8K $ | 1.82 % |
| 23 | Crinetics Pharmaceuticals Inc | 5,065 | 184K $ | 1.81 % |
| 24 | Nektar Therapeutics | 2,554 | 183.8K $ | 1.81 % |
| 25 | Liquidia Corp | 4,857 | 183.3K $ | 1.80 % |
| 26 | Amneal Pharmaceuticals Inc | 14,735 | 183.2K $ | 1.80 % |
| 27 | Harmony Biosciences Holdings Inc | 6,505 | 182.2K $ | 1.79 % |
| 28 | Supernus Pharmaceuticals Inc | 3,519 | 181.9K $ | 1.79 % |
| 29 | Viatris Inc | 13,406 | 181.1K $ | 1.78 % |
| 30 | Xeris Biopharma Holdings Inc | 30,952 | 179.5K $ | 1.77 % |
| 31 | Harrow Inc | 5,070 | 178.8K $ | 1.76 % |
| 32 | Organon & Co | 29,264 | 175.3K $ | 1.72 % |
| 33 | Nuvation Bio Inc | 40,803 | 175K $ | 1.72 % |
| 34 | Phibro Animal Health Corp | 3,161 | 174.8K $ | 1.72 % |
| 35 | Amylyx Pharmaceuticals Inc | 12,544 | 174.4K $ | 1.71 % |
| 36 | Indivior Pharmaceuticals Inc | 5,705 | 173.9K $ | 1.71 % |
| 37 | Collegium Pharmaceutical Inc | 5,258 | 173.9K $ | 1.71 % |
| 38 | Eli Lilly & Co | 187 | 172K $ | 1.69 % |
| 39 | Prestige Consumer Healthcare Inc | 2,890 | 171.3K $ | 1.68 % |
| 40 | Ligand Pharmaceuticals Inc | 847 | 169.1K $ | 1.66 % |
| 41 | Ocular Therapeutix Inc | 19,715 | 167K $ | 1.64 % |
| 42 | Omeros Corp | 15,699 | 165.8K $ | 1.63 % |
| 43 | EyePoint Inc | 12,553 | 161.8K $ | 1.59 % |
| 44 | Alumis Inc | 7,110 | 156.6K $ | 1.54 % |
| 45 | Amphastar Pharmaceuticals Inc | 7,223 | 141.5K $ | 1.39 % |
| 46 | Phathom Pharmaceuticals Inc | 12,655 | 140.6K $ | 1.38 % |
| 47 | Theravance Biopharma Inc | 8,528 | 138.4K $ | 1.36 % |
| 48 | Rapport Therapeutics Inc | 4,267 | 133.5K $ | 1.31 % |
| 49 | Arvinas Inc | 11,487 | 121.8K $ | 1.20 % |
| 50 | CorMedix Inc | 17,585 | 119.4K $ | 1.17 % |
| 51 | BioAge Labs Inc | 6,693 | 117.1K $ | 1.15 % |
| 52 | Maze Therapeutics Inc | 3,713 | 110.8K $ | 1.09 % |
| 53 | Septerna Inc | 4,081 | 98.1K $ | 0.96 % |
| 54 | WaVe Life Sciences Ltd | 13,302 | 96.4K $ | 0.95 % |
| 55 | Zevra Therapeutics Inc | 10,307 | 96.1K $ | 0.94 % |
| 56 | Fulcrum Therapeutics Inc | 11,666 | 89.5K $ | 0.88 % |
| 57 | Aquestive Therapeutics Inc | 19,045 | 79K $ | 0.78 % |
| 58 | LB Pharmaceuticals Inc | 2,830 | 69.8K $ | 0.69 % |
| 59 | Alto Neuroscience Inc | 2,325 | 52.3K $ | 0.51 % |
Sector breakdown
- Health care 15.3 %
- Unattributed 84.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 93.0 %
- Ireland 4.1 %
- Canada 1.9 %
- Singapore 1.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 55 | 9.1M $ | 93.01 % |
| 2 | Ireland | 2 | 396K $ | 4.06 % |
| 3 | Canada | 1 | 190K $ | 1.95 % |
| 4 | Singapore | 1 | 96.4K $ | 0.99 % |
Cite this page
Titelia. "Holdings of PROFUND VP PHARMACEUTICALS". https://titelia.com/en/funds/S000003975